Paxman AB (publ) (STO:PAX)

Market Cap	1.19B
Revenue (ttm)	305.02M
Net Income (ttm)	4.77M
Shares Out	23.27M
EPS (ttm)	0.23
PE Ratio	217.29
Forward PE	38.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,379
Average Volume	24,261
Open	50.60
Previous Close	51.00
Day's Range	50.40 - 52.40
52-Week Range	50.60 - 85.80
Beta	0.48
RSI	35.69
Earnings Date	Feb 20, 2026

About Paxman AB

Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to develop a wearable medical cooling device; and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 105
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: PAX

Financial Performance

In 2024, Paxman AB's revenue was 263.20 million, an increase of 19.30% compared to the previous year's 220.61 million. Earnings were 40.20 million, an increase of 382.55%.